iifl-logo-icon 1

Emcure Pharmaceuticals Ltd Corporate Actions

1,212.75
(-5.64%)
Feb 7, 2025|03:31:27 PM

CORPORATE ACTIONS

10/02/2024calendar-icon
09/02/2025calendar-icon

24 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Emcure Pharmaceuticals Ltd: Related News

Emcure Pharma Posts 38% Profit Growth in Q2
11 Nov 2024|11:43 AM

EBITDA margin slightly declined, down 80 basis points to 20.8% in Q2, reflecting some operational pressures.

Read More
Emcure Pharma Soars 34.8% on NSE at Close
10 Jul 2024|03:39 PM

The allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.

Read More
Emcure Pharmaceuticals Lists at 31% Premium on the Bourses
10 Jul 2024|09:52 AM

The IPO comprised a mix of fresh equity sale and an offer for sale (OFS).

Read More
Emcure Pharma IPO Soars: Oversubscribed 66 Times on Day 3
5 Jul 2024|03:59 PM

The categories earmarked for NII and QIB investors received the most subscriptions, at 47.98 and 193.06 times, respectively.

Read More
Emcure Pharmaceuticals IPO subscribed 4.98 times on Day 2
5 Jul 2024|09:03 AM

The IPO is priced between Rs 960 and Rs 1008 a share, with buyers able to bid for 14 shares per lot.

Read More
Emcure Pharmaceuticals IPO Subscribed 1.32 times
4 Jul 2024|08:40 AM

According to BSE data, the initial share sale attracted bids for 1,80,40,960 shares, with 1,37,03,538 shares on offer.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.